Lineage Cell Therapeutics In shares owned by Riggs Asset Managment
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Riggs Asset Managment
from 13F filings
Historical chart of Riggs Asset Managment investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by Riggs Asset Managment consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lineage Cell Therapeutics In by Riggs Asset Managment
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $14k | 9.6k | 1.48 |
| 2023-12-31 | $11k | 9.6k | 1.09 |
| 2023-09-30 | $13k | 11k | 1.18 |
| 2023-06-30 | $15k | 11k | 1.41 |
| 2023-03-31 | $16k | 11k | 1.50 |
| 2022-12-31 | $12k | 11k | 1.17 |
| 2022-09-30 | $12k | 11k | 1.13 |
| 2022-06-30 | $17k | 11k | 1.60 |
| 2022-03-31 | $16k | 11k | 1.51 |
| 2021-12-31 | $26k | 11k | 2.45 |
| 2021-09-30 | $27k | 11k | 2.55 |
| 2021-06-30 | $30k | 11k | 2.83 |
| 2021-03-31 | $25k | 11k | 2.36 |
| 2020-12-31 | $19k | 11k | 1.79 |
| 2020-06-30 | $10k | 12k | 0.86 |
| 2020-03-31 | $9.0k | 12k | 0.78 |
| 2019-12-31 | $10k | 12k | 0.86 |
| 2019-09-30 | $11k | 12k | 0.95 |